Related Experiment Video
Updated: Jul 31, 2025
07:56
Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis
Published on: June 10, 2022
2.9K
Label-free characterization of organoids with quantitative confocal Raman spectral imaging
Mark F Coughlan1, Lev T Perelman1
1Center for Advanced Biomedical Imaging and Photonics, Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA 02215, USA.
Cell Reports Methods
|May 9, 2023
Summary
Quantitative confocal Raman spectral imaging offers a label-free method to monitor stem cell-derived organoid development and drug responses. This technique reliably tracks organoid maturation, drug accumulation, and metabolism for improved drug discovery.
Area of Science:
- Biomedical Engineering
- Cell Biology
- Pharmacology
Background:
- Stem cell-derived organoids are promising tools for drug discovery but lack robust monitoring methods for maturation and drug response.
- Current methods for assessing organoid development and drug interactions are often indirect or require labeling.
Discussion:
- Quantitative confocal Raman spectral imaging provides a label-free approach to analyze organoid systems.
- This technique enables real-time monitoring of organoid maturation, including cellular changes and structural development.
Key Insights:
- LaLone et al. demonstrate the efficacy of Raman spectral imaging in tracking organoid development and maturation.
- The study shows this method can reliably quantify drug accumulation within organoids.
- Raman imaging also allows for the assessment of drug metabolism within the organoid model.
Outlook:
- This label-free imaging technique has the potential to significantly enhance the efficiency and accuracy of drug discovery pipelines.
- Further application of Raman spectral imaging could accelerate the development of personalized medicine through organoid models.
